PMDD (Premenstrual Dysphoric Disorder)

What Is PMDD?

Premenstrual dysphoric disorder (PMDD) is a severe, cyclical mood disorder tied to the menstrual cycle. In the week or two before a period, it brings depression, anxiety, irritability or rage intense enough to disrupt work, relationships and daily life. Then, within a few days of bleeding starting, the symptoms lift, and they are minimal or gone in the week after the period.

PMDD is the most severe form of premenstrual disorder. It is not “bad PMS” and it is not a personality flaw. It has been an official psychiatric diagnosis in the DSM since 2013, and it is also listed in the World Health Organization’s ICD-11.

The most important thing to understand about PMDD is that hormone levels are normal. The problem is how the brain responds to the normal rise and fall of those hormones.

PMDD Symptoms

To be diagnosed with PMDD, a person needs at least five of these eleven symptoms, and at least one must come from the first four core mood symptoms.

Core Mood Symptoms (At Least One)

  1. Markedly depressed mood, hopelessness or self-critical thoughts
  2. Marked anxiety or tension, feeling “keyed up” or on edge
  3. Marked mood swings, such as suddenly feeling sad or tearful, or being very sensitive to rejection
  4. Persistent, marked anger or irritability, or more conflict with other people

Other Symptoms

  1. Less interest in usual activities
  2. Difficulty concentrating
  3. Lethargy, fatigue or low energy
  4. Marked appetite changes, overeating or food cravings
  5. Sleeping much more or much less than usual
  6. Feeling overwhelmed or out of control
  7. Physical symptoms such as breast tenderness or swelling, headaches, joint or muscle pain, bloating or weight gain

The timing is what defines it. Symptoms appear in the final week before a period, start improving within a few days after bleeding begins, and are minimal or absent the week after. They must also cause real impairment, in work, school, relationships, social life or sex.

How Common Is PMDD?

The best current estimate comes from a 2024 meta-analysis of 44 studies and more than 50,000 people:

  • 3.2% of people who menstruate meet the full criteria when symptoms are confirmed by daily tracking, about 1 in 30.
  • 7.7% meet criteria based on recalled symptoms alone, a figure the researchers say likely overstates the true rate.

You will see other figures: the National Institute of Mental Health cites 2% to 5%. The differences come mostly from whether studies required daily symptom tracking.

PMDD vs. PMS

PMS PMDD
How common About one-third of women with premenstrual symptoms; most women have at least some symptoms About 3%, confirmed by daily tracking
Main symptoms Often physical, with milder mood changes Mood symptoms are central: depression, anxiety, irritability, rage
Severity Uncomfortable but manageable Disrupts work, relationships and daily functioning
Diagnosis Clinical symptoms At least 5 of 11 symptoms confirmed over two cycles of daily ratings

PMDD is also different from premenstrual exacerbation (PME), when an existing condition such as depression, anxiety or bipolar disorder gets worse before a period. In PME, symptoms are present all month and intensify premenstrually; in PMDD, they largely disappear after the period.

What Causes PMDD?

  • Sensitivity to normal hormone changes. In a landmark National Institutes of Health study, shutting down the ovaries relieved symptoms, and adding estrogen or progesterone back brought symptoms back only in women with premenstrual symptoms. The researchers concluded that symptoms are “an abnormal response to normal hormonal changes.”
  • Serotonin. Antidepressants that act on serotonin work quickly in PMDD, and blocking serotonin brought symptoms back within a day in women whose PMDD had gone into remission.
  • Allopregnanolone and GABA. A byproduct of progesterone normally has a calming effect on the brain’s GABA system; in PMDD, that response appears blunted. This is a leading theory, not a settled explanation.
  • Genes. An NIH lab study found that cells from women with PMDD handle hormone signals differently at a molecular level. It was a small study of cell lines, but the NIH researchers described it as evidence of “an intrinsic difference” rather than something women should be able to control.

How PMDD Is Diagnosed

There is no blood, saliva or hormone test for PMDD. Lab tests can rule out other conditions, but the diagnosis depends on tracking.

  • Track symptoms daily for at least two full cycles. The standard tool is the Daily Record of Severity of Problems (DRSP). The International Association for Premenstrual Disorders (IAPMD) offers a free tracker based on it.
  • Online “PMDD tests” and questionnaires that ask you to remember past cycles can only suggest a provisional diagnosis.
  • Your clinician will rule out premenstrual worsening of another condition, and check whether both are present.

A gynecologist, psychiatrist or primary care doctor can diagnose PMDD. Many clinicians are not familiar with it, so bringing two months of tracked symptoms makes the conversation much easier. In the U.S. diagnostic coding system, PMDD is coded F32.81.

PMDD and Suicidal Thoughts

PMDD carries a real and serious risk of suicidal thoughts. Two meta-analyses both found higher risk, though they disagree on how much: one found roughly four times the odds of suicidal thoughts and seven times the odds of a suicide attempt; another, using studies with less precise diagnoses, found about twice the odds. Reviews agree that people with PMDD should be treated as a high-risk group.

If you have thoughts of ending your life, even if you know they will pass when your period starts, they deserve help now. Call or text 988 for the Suicide and Crisis Lifeline, free and available 24 hours a day. If you are in immediate danger, call 911.

PMDD and Postpartum Depression

PMDD and postpartum depression appear to share a vulnerability: sensitivity to shifts in reproductive hormones. That sensitivity may matter again later in life; see perimenopause depression, perimenopause anxiety and perimenopause rage.

  • In a Swedish national registry study of about 1 million women, a prior premenstrual disorder was linked to about 2.7 times the odds of perinatal depression and about four times the odds of perinatal bipolar disorder.
  • A meta-analysis of 19 studies found that a history of premenstrual symptoms before pregnancy more than doubled the odds of postpartum depression, although the quality of that evidence was low.
  • A history of PMDD is also linked to depressive symptoms in the first days after birth.

If you have PMDD and are pregnant or planning a pregnancy, tell your ob-gyn or midwife. It is a reason to screen closely during pregnancy and after birth, and you can check yourself any time with the Edinburgh scale calculator or the PHQ-9.

PMDD and ADHD

Several studies have found PMDD is more common in people with ADHD. In one clinic study of 209 women with ADHD, both PMDD and postpartum depression were more common than in the general population, and a survey of 2,000 working women linked ADHD traits to much higher odds of PMDD. These are associations from early research, and it is not known whether one condition causes the other, but if you have ADHD and your symptoms worsen before your period, PMDD is worth raising.

PMDD Treatment

PMDD is treatable; see PMDD treatment for every option in detail. Antidepressants that act on serotonin (SSRIs) are the first-line treatment and often work within days, which means some people only take them in the two weeks before their period. Other options include a specific birth control pill, cognitive behavioral therapy, and, for severe cases, medications that pause the menstrual cycle. See the full guide to PMDD treatment.

Find a therapist who understands reproductive mood disorders

Myths About PMDD

  • “It’s a hormone imbalance, so get your hormones tested.” Hormone levels are typically normal. PMDD is a sensitivity to normal changes, and no hormone test can diagnose it.
  • “It’s just bad PMS” or “it’s all in your head.” It is a distinct, recognized diagnosis that requires real impairment.
  • “An online quiz can tell me I have PMDD.” Only two cycles of daily tracking can confirm it.
  • “Pepcid and Allegra cure PMDD.” No clinical trials have tested this combination. See PMDD treatment for what the evidence supports.
  • “I can cure it naturally.” No supplement or diet has been shown to cure PMDD. Some have weak evidence for easing symptoms.

Frequently Asked Questions

What does PMDD stand for?

Premenstrual dysphoric disorder, a severe mood disorder that occurs in the one to two weeks before a period and improves after bleeding starts.

What are the 11 symptoms of PMDD?

Depressed mood, anxiety or tension, mood swings, irritability or anger, less interest in activities, difficulty concentrating, fatigue, appetite changes or cravings, sleep changes, feeling overwhelmed, and physical symptoms such as breast tenderness, bloating or headaches. At least five are needed, including one of the first four.

How is PMDD different from PMS?

PMDD is far more severe, centers on mood symptoms, and disrupts daily life. PMS is common and usually manageable; PMDD affects about 3% of people who menstruate.

Is there a test for PMDD?

No blood or hormone test can diagnose it. Diagnosis requires tracking symptoms daily for at least two menstrual cycles, often with the DRSP.

What causes PMDD?

An abnormal brain response to the normal rise and fall of estrogen and progesterone, involving serotonin and possibly the brain’s GABA system and genetic differences in how cells respond to hormones.

Can PMDD cause suicidal thoughts?

Yes. PMDD is linked to significantly higher rates of suicidal thoughts and attempts. If you have these thoughts, call or text 988.

Does PMDD increase the risk of postpartum depression?

Yes. A history of premenstrual disorders is linked to higher odds of depression during pregnancy and after birth.

What is the ICD-10 code for PMDD?

PMDD is coded F32.81 in ICD-10-CM, the U.S. diagnostic coding system.

PostpartumDepression.org Team
Written by:

Jenna Carberg was diagnosed with postpartum depression following the birth of her daughter in 2016. It was a healthy birth but in the following days, Jenna's mood changed quickly. Doctors suggested that it might be the "baby blues", but her husband Chris suggested she seek a second opinion. Jenna was diagnosed with postpartum depression and began a journey that lasted 9 long months with significant ups and downs. Jenna's mental health care and her experiences became a passion for her to share with the world. She and her husband Chris founded PostpartumDepression.org as a support website designed to help women suffering in silence and their loved ones.

  1. Miller C, Carlson K. “Premenstrual Disorders.” StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated August 9, 2026. https://www.ncbi.nlm.nih.gov/books/NBK532307/. Accessed September 15, 2026.
  2. Reilly TJ, Patel S, Unachukwu IC, et al. “The prevalence of premenstrual dysphoric disorder: Systematic review and meta-analysis.” Journal of Affective Disorders. 2024;349:534-540. https://doi.org/10.1016/j.jad.2024.01.066.
  3. Find-A-Code. “GA34.41 Premenstrual dysphoric disorder – ICD-11 MMS.” https://www.findacode.com/icd-11/code-1526774088.html. Accessed September 15, 2026.
  4. AAPC. “ICD-10-CM Code for Premenstrual dysphoric disorder F32.81.” https://www.aapc.com/codes/icd-10-codes/F32.81. Accessed September 15, 2026.
  5. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. “Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.” The New England Journal of Medicine. 1998;338(4):209-216. https://doi.org/10.1056/NEJM199801223380401.
  6. Dubey N, Hoffman JF, Schuebel K, et al. “The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder.” Molecular Psychiatry. 2017;22(8):1172-1184. https://doi.org/10.1038/mp.2016.229.
  7. National Institute of Mental Health. “Sex Hormone-Sensitive Gene Complex Linked to Premenstrual Mood Disorder.” https://www.nimh.nih.gov/news/science-updates/2017/sex-hormone-sensitive-gene-complex-linked-to-premenstrual-mood-disorder. Accessed September 15, 2026.
  8. International Association for Premenstrual Disorders. “What is PMDD?” https://www.iapmd.org/pmdd. Accessed September 15, 2026.
  9. International Association for Premenstrual Disorders. “Steps to Diagnosis.” https://www.iapmd.org/steps-to-diagnosis. Accessed September 15, 2026.
  10. Prasad D, Wollenhaupt-Aguiar B, Kidd KN, de Azevedo Cardoso T, Frey BN. “Suicidal Risk in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Systematic Review and Meta-Analysis.” Journal of Women’s Health. 2021;30(12):1693-1707. https://doi.org/10.1089/jwh.2021.0185.
  11. Yan H, Ding Y, Guo W. “Suicidality in patients with premenstrual dysphoric disorder-A systematic review and meta-analysis.” Journal of Affective Disorders. 2021;295:339-346. https://doi.org/10.1016/j.jad.2021.08.082.
  12. Osborn E, Brooks J, O’Brien PMS, Wittkowski A. “Suicidality in women with Premenstrual Dysphoric Disorder: a systematic literature review.” Archives of Women’s Mental Health. 2021;24(2):173-184. https://doi.org/10.1007/s00737-020-01054-8.
  13. Eisenlohr-Moul T, Divine M, Schmalenberger K, et al. “Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder.” BMC Psychiatry. 2022;22(1):199. https://doi.org/10.1186/s12888-022-03851-0.
  14. Zhitnik E, Britt T, Bertone-Johnson E, Mackie TI, Hartmann-Boyce J. “Prevalence, Risk Factors, and Treatments for Suicidality in People Living with Premenstrual Dysphoric Disorder (PMDD): A Systematic Review.” Administration and Policy in Mental Health. 2026;53(4):402-419. https://doi.org/10.1007/s10488-026-01504-y.
  15. 988 Suicide & Crisis Lifeline. “988 Lifeline.” https://988lifeline.org/. Accessed September 15, 2026.
  16. Marjoribanks J, Brown J, O’Brien PMS, Wyatt K. “Selective serotonin reuptake inhibitors for premenstrual syndrome.” Cochrane Database of Systematic Reviews. 2013;(6):CD001396. https://doi.org/10.1002/14651858.CD001396.pub3.
  17. Dorani F, Bijlenga D, Beekman ATF, van Someren EJW, Kooij JJS. “Prevalence of hormone-related mood disorder symptoms in women with ADHD.” Journal of Psychiatric Research. 2021;133:10-15. https://doi.org/10.1016/j.jpsychires.2020.12.005.
  18. Tsuji R, Watanabe K, Egawa M, et al. “Association of ADHD/ASD traits with premenstrual dysphoric disorder among full-time employed women in Japan: A cross-sectional study.” Journal of Psychiatric Research. 2025;192:371-377. https://doi.org/10.1016/j.jpsychires.2025.10.059.
  19. Cao S, Jones M, Tooth L, Mishra GD. “History of premenstrual syndrome and development of postpartum depression: A systematic review and meta-analysis.” Journal of Psychiatric Research. 2020;121:82-90. https://doi.org/10.1016/j.jpsychires.2019.11.010.
  20. Schleimann-Jensen E, Sundström-Poromaa I, Meltzer-Brody S, et al. “Trajectories and dimensional phenotypes of depressive symptoms throughout pregnancy and postpartum in relation to prior premenstrual symptoms.” The British Journal of Psychiatry. 2025;226(6):401-409. https://doi.org/10.1192/bjp.2025.38.
  21. Verberne NE, Yan J, Bränn E, et al. “Risk of perinatal psychiatric disorder among women with a history of premenstrual disorder: a nationwide register-based study from Sweden.” BMJ Open. 2026;16(6):e116361. https://doi.org/10.1136/bmjopen-2026-116361.
  22. Roca CA, Schmidt PJ, Smith MJ, Danaceau MA, Murphy DL, Rubinow DR. “Effects of metergoline on symptoms in women with premenstrual dysphoric disorder.” The American Journal of Psychiatry. 2002;159(11):1876-1881. https://doi.org/10.1176/appi.ajp.159.11.1876.
  23. Bloch M, Rotenberg N, Koren D, Klein E. “Risk factors for early postpartum depressive symptoms.” General Hospital Psychiatry. 2006;28(1):3-8. https://doi.org/10.1016/j.genhosppsych.2005.08.006.